{"id":3122,"date":"2016-02-26T06:42:36","date_gmt":"2016-02-26T06:42:36","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=5928"},"modified":"2016-02-26T06:42:36","modified_gmt":"2016-02-26T06:42:36","slug":"axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/","title":{"rendered":"AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview"},"content":{"rendered":"<h3 class=\"subheadline\">AXIM\u00ae Biotech Discusses Patented Cannabinoid-Release Chewing Gum \u2013 MedChew RX\u2122; Future Patent-Pending Products Including: Oral Care, Skin Care, Suppository, and Ocular Treatments<\/h3>\n<p align=\"left\">SAN DIEGO, Feb. 25, 2016 (GLOBE NEWSWIRE) \u2014 Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to the public and its shareholders that its <a title=\"portfolio investment\" href=\"https:\/\/medicalmarijuanainc.com\/about\/portfolio\/\" target=\"_blank\" rel=\"nofollow noopener\">portfolio investment<\/a>, <a href=\"https:\/\/medicalmarijuanainc.com\/companies\/axim-biotechnologies\/\" target=\"_blank\" rel=\"noopener\">AXIM<sup>\u00ae<\/sup> Biotechnologies, Inc. (OTC:AXIM)<\/a>, participated in a recent <a title=\"interview\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=xpvZMLOWsEtaty1QWr0qcfQ9OcjDRGu-mcpbEd9CsBhbRctxCyUmpU8SbR_0SLxn1EsuaGchp7RjvJVg3-Tef9DKd8y9PscwGvpK24V0236AhEQQ9K2edRVk8GByIEEK_2F9A5ec-SXEraSc5mXpWyy3HVJuq3zaziAsBiLSvwg=\" target=\"_blank\" rel=\"nofollow noopener\">interview<\/a> and unveiled the hemp innovator\u2019s intellectual property (IP)-protected cannabis-based research and product development roadmap.<\/p>\n<p>\u201cWe are extremely enthusiastic about AXIM Biotech\u2019s position in the cannabis industry as a leader in cannabinoid research and development,\u201d states <a href=\"https:\/\/medicalmarijuanainc.com\/company\/#leadership\" target=\"_blank\" rel=\"noopener\">Dr. Stuart W. Titus, Chief Executive Officer of Medical Marijuana, Inc.<\/a> \u201cTheir efforts have the potential to expedite cannabis\u2019 return to the global healthcare market, as early as 2017.\u201d Listen to the interview below:<\/p>\n<p><iframe loading=\"lazy\" src=\"https:\/\/w.soundcloud.com\/player\/?url=https%3A\/\/api.soundcloud.com\/tracks\/244799785&amp;auto_play=false&amp;hide_related=false&amp;show_comments=true&amp;show_user=true&amp;show_reposts=false&amp;visual=true\" width=\"100%\" height=\"150\" frameborder=\"no\" scrolling=\"no\"><\/iframe><\/p>\n<p><a href=\"https:\/\/medicalmarijuanainc.com\/companies\/axim-biotechnologies\/\" target=\"_blank\" rel=\"noopener\">AXIM<sup>\u00ae<\/sup> Biotech\u2019s Chief Executive Officer, Dr. George E. Anastassov, MD, DDS, MBA<\/a>, explains in the\u00a0interview the unique proprietary delivery mechanisms for the introduction of cannabinoids (i.e. <a href=\"https:\/\/medicalmarijuanainc.com\/medicinal-value-of-tetrahydrocannabinol-thc\/\" target=\"_blank\" rel=\"noopener\">THC<\/a>, <a href=\"https:\/\/medicalmarijuanainc.com\/education\/\" target=\"_blank\" rel=\"noopener\">CBD<\/a>, CBG, <a href=\"https:\/\/medicalmarijuanainc.com\/medicinal-value-of-cannabinol-cbn\/\" target=\"_blank\" rel=\"noopener\">CBN<\/a>, etc.).<\/p>\n<p>The Company\u2019s goal is finding solutions for conditions for which there is currently no effective treatment. Indications that AXIM<sup>\u00ae<\/sup> is pursuing through research and development include: <a title=\"MS\" href=\"https:\/\/medicalmarijuanainc.com\/multiple-sclerosis-medical-marijuana-research\/\" target=\"_blank\" rel=\"nofollow noopener\">MS<\/a>, spasticity, <a href=\"https:\/\/medicalmarijuanainc.com\/pain-medical-marijuana-research\/\" target=\"_blank\" rel=\"noopener\">pain<\/a>,\u00a0<a href=\"https:\/\/medicalmarijuanainc.com\/parkinsons-disease-medical-marijuana-research\/\" target=\"_blank\" rel=\"noopener\">Parkinson\u2019s disease<\/a>, <a href=\"https:\/\/medicalmarijuanainc.com\/parkinsons-disease-medical-marijuana-research\/\" target=\"_blank\" rel=\"noopener\">Alzheimer\u2019s disease<\/a>\/dementia, ADHD (attention deficit hyperactivity disorder), psychosis, <a href=\"https:\/\/medicalmarijuanainc.com\/ptsd-medical-marijuana-research\/\" target=\"_blank\" rel=\"noopener\">PTSD<\/a>, <a href=\"https:\/\/medicalmarijuanainc.com\/autism-medical-marijuana-research\/\" target=\"_blank\" rel=\"noopener\">autism<\/a>, RLS (restless leg syndrome), <a href=\"https:\/\/medicalmarijuanainc.com\/glaucome-medical-marijuana-research\/\" target=\"_blank\" rel=\"noopener\">glaucoma<\/a>, <a href=\"https:\/\/medicalmarijuanainc.com\/crohns-disease-medical-marijuana-research-overview\/\" target=\"_blank\" rel=\"noopener\">IBD<\/a>, <a href=\"https:\/\/medicalmarijuanainc.com\/crohns-disease-medical-marijuana-research-overview\/\" target=\"_blank\" rel=\"noopener\">IBS<\/a>, and <a title=\"Crohn\u2019s\" href=\"https:\/\/medicalmarijuanainc.com\/crohns-disease-medical-marijuana-research-overview\/\" target=\"_blank\" rel=\"nofollow noopener\">Crohn\u2019s<\/a> disease.<\/p>\n<p>AXIM\u2019s pipeline of intellectual property (IP) protected cannabinoid-based products include:<\/p>\n<ul type=\"disc\">\n<li>MedChew RX\u2122 \u2013 THC\/CBD cannabinoid-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients<\/li>\n<li>RENECANN\u2122 \u2013 the world\u2019s first cannabigerol (CBG)-based skincare product line<\/li>\n<li>ORAXIMAX\u2122 \u2013 the world\u2019s first CBG-based oral care product line<\/li>\n<li>Suppocann\u2122 \u2013 a suppository cannabinoid-release product for GI conditions such as IBD, IBS and Crohn\u2019s disease<\/li>\n<li>Ophthocann\u2122\u00a0 and Cannbleph\u2122 \u2013 cannabinoid-based products for reduction of intraocular pressure and for relief of conjunctivitis<\/li>\n<\/ul>\n<p>Recent news about AXIM\u2019s mission is spreading from the U.S. to <a title=\"Canada\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=VkNtUQRe9E4xbhE1QZW15eu59putbkX-2ntMho2k5S8aWcr5AZSUvIVsAdULhwY9XfzehQwqSwxk-ee3Uur37xI1_1DmvQC2u0HsdHEscdxL5Z_pjEeIHSpss_gIuPjZ29ndbr2Ozaxr6XjiciisfmDnn91p36CZe_RTT50BCB06mkcpGFTcRrvxxq3ZMajw4Y8Qzd88PP-osaCJOEP3HRE8dNuXm_oUvdX_9DYMq0H1e50anY57-DxU01e0hSXK9emT1Alqo3o0CfWiiN-oOEDRcT99TYEL-ULbTlxIBjY=\" target=\"_blank\" rel=\"nofollow noopener\">Canada<\/a>, <a title=\"New Zealand\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=ujjLYZDSX_oyoYs1SfJi1YK5PQGiNccF1kcV9cDUJrYhw46ZAmaxMQJAk8htzo2r7KBE2qr0fPbHk9WVPJIS-Av7vDOwl1pLq6FFal_MdshqlhMwY_OmjTFTAkjDw2-7ZXV2PWhppZCt6TfbVGSK1Y7ha0EdrzTrBmX_vLvwjTg=\" target=\"_blank\" rel=\"nofollow noopener\">New Zealand<\/a> and beyond, including\u00a0<a title=\"Yahoo Finance\" href=\"http:\/\/globenewswire.com\/Tracker?data=UglyLCzFTy60DorRA7vaX-miqhwfDO4DQTFM_5M-FGOvjU8ej2I26BeFz5Vwg9tr-o1hAGRQwn-XTrmqFgOV5vJQhFUXQXc04yhYZ5lB9p4gWGGISSOVZwJMe1tQA6LuwSWpxUXfaTq6ph1sgu40gA%3D%3D\" target=\"_blank\" rel=\"nofollow noopener\">Yahoo Finance<\/a>,\u00a0<a title=\"The Stock Radio.com\" href=\"http:\/\/globenewswire.com\/Tracker?data=dbKbSsxj1JrEb-3TkU6Z9_J724iGBMtYniCUesni_fRNIlQNy1eDOK0JW9iMEB2cmAAgsbxD5Y4oK0J0-s12evca4nrOjFJXhWNAsRVC72kLtV75p2g0AB-_cr-SM9n7pt3X0s078XPgEQBpewzK3bUUho8I2dO8QoxGdfXStBI%3D\" target=\"_blank\" rel=\"nofollow noopener\">The Stock Radio.com<\/a>,\u00a0<a title=\"The Street\" href=\"http:\/\/globenewswire.com\/Tracker?data=3kJPvpKMPMhsAfN1mnEFl0smAr3t38QsQyf6TbeCXt_vSnjuFptzISyKFu-0Nq9gLaIpaA36j79sAQaZ-Ox9OVEQpV_JssTiCfgkcIlcJPo48ORvbrFEEwgFsEXDkjixfhQYAIV7oISYOxJxBYFqQH0LMsvL_yuDOS9GRjOgTlA9cXSkHZOfYKKfKNZtJ0EqoudYqyWG-jZZdyKx_6kmu6xKHknZfB3Jx3GZdbWaHIMgty5278Jse0JJvhe057AGK8SoM_SgYQU-2a2LmlO74ylyWBKLeqUwyqhQSL-Zzqk%3D\" target=\"_blank\" rel=\"nofollow noopener\">The Street<\/a>,\u00a0<a title=\"Westbrook Radio\" href=\"http:\/\/globenewswire.com\/Tracker?data=ylmoy9i2GYy50_l7Q7ZfK1l-pNfVoHTJK6fSsOa8OMcvut1kd-VzNPpTJFtFTSeKyfkJnDmkptXN5KpZK5q0v1TqlIfGZ7OjChY7Wz0VGLm2SHu3ihmjtSnRvWWHc-gZTzxWj97P3Rkmbi7Fug0ehrSLzo6o7PqS02tOspZmw4I%3D\" target=\"_blank\" rel=\"nofollow noopener\">Westbrook Radio<\/a>,\u00a0<a title=\"Small Cap Voice\" href=\"http:\/\/globenewswire.com\/Tracker?data=1FryU_KCy8xZCTiPxu26Gn1p5pZ15dOyjbT_FgETiKoAGi5N9lPxwEw7jyIAjzJBA_WYc_4HVq0GY9HcjWjWyPW8jJsbWl1E4ZRx4GY4maC5QSOmNCutE9cyTvvkHOIqqCSURd4asuJSoRca231GxJV80xFsTG7XNW4zEOuZBRE%3D\" target=\"_blank\" rel=\"nofollow noopener\">Small Cap Voice<\/a>,\u00a0<a title=\"Inquisitr.com\" href=\"http:\/\/globenewswire.com\/Tracker?data=w_22MWwaHAPEmfUnNXycC30cAcF8nab99BcFlqd1KwEUlLnPF0ZX2fUC_Un-xvpG_-77oyoph3jvBQRXhPY-bspmxgwzbUH77KlnTk5kp-bIcMAJ27-5sbkqifSd8cF78gCkgHbregKfTKGkVoFX4yPsYVcm5WPW39P-CRpTyW2OI2-q3lxHE5jxfP55_QCB-AIpcgp4SutZ9UhpmvOQkR2rdaIOTqrh-5zEsnyiipM%3D\" target=\"_blank\" rel=\"nofollow noopener\">Inquisitr.com<\/a>,\u00a0<a title=\"Basis Home Infusion.com\" href=\"http:\/\/globenewswire.com\/Tracker?data=VDdLLV03VKdYqIJj7LU0vI6evyXimmo9epOzHuIP2wkQBuUy3uQi9RgsftheqSUf9bXLbSaus8AJIg_g5E8tLj50BWyY8CjvFfXMhjP0sRlAK_6t6ppWUhSfxGzHuMIs\" target=\"_blank\" rel=\"nofollow noopener\">Basis Home Infusion.com<\/a>,\u00a0<a title=\"The Blessed Source.com\" href=\"http:\/\/globenewswire.com\/Tracker?data=zZMpb8CMhAcMVcXBOpJNl4JB5bQGwZ7giAhIUA0TgpnlLeKJeNCS5KCWn7_ZTQHMSFR9K522fBCOaYJsApHdIz9ViTjVYGAmwwET_a8WKF60F6waGaghNQkTOPkyKbYNZBeLexhPNjYWGNGYr3x_sA%3D%3D\" target=\"_blank\" rel=\"nofollow noopener\">The Blessed Source.com<\/a>,\u00a0<a title=\"Releaf\" href=\"http:\/\/globenewswire.com\/Tracker?data=9XqInJiDXkFEMgWpcIUWjtiqYvgZI1GYZCvmNMOtRbuY2YHlpeNjBr1nIJuoth_B\" target=\"_blank\" rel=\"nofollow noopener\">Releaf<\/a>,\u00a0<a title=\"Penny Detective\" href=\"http:\/\/globenewswire.com\/Tracker?data=eTGPiODJ-BKvhad_NBcQRMRIxJLJIhFkC7U3eKzTg7Kmnyn-pQbcxW4R1Z9j0yide5gttELNzjwOGRvJi8z8isiYkiTfHW94xQNaDjhIAtmp9iQaN18vEOMevq3lJ1PS5X3tnXlV1-1liDWaiTFQ2eCipn0g0ZM0Jf6Od8j_4PQ%3D\" target=\"_blank\" rel=\"nofollow noopener\">Penny Detective<\/a>,\u00a0<a title=\"Winning Pennies\" href=\"http:\/\/globenewswire.com\/Tracker?data=SOfKV2eFh_cn3xhn6YDukLkCQFreV-oJgcnw_vlPhjVkB32IPd89IYIZb6rWcgjUTE3pPGsv8Rtg0YyCuywzKnxytSD-ax5uDfaQ-ZSBlIu2aYgwVP9tLYcRWT1TduD7Li8DgeBCf5hdMA5Y48AROkFZHQPNYbWERtBK6r3GIJ0%3D\" target=\"_blank\" rel=\"nofollow noopener\">Winning Pennies<\/a>,\u00a0<a title=\"Morning Star\" href=\"http:\/\/globenewswire.com\/Tracker?data=kx94Df3ed6wPXDtvJA8VcDW6db-SmG80HHORDSC7FXemBxhCjBmZsiU3-eS50Th0GoE6KNQzhNVBNzd1GlXPr8Q9TjCZSFDS1RaVCAx0AM6oe50PpCFJ41jwx3LL7-KAo4poxPWovcdNaChpE-u18Dr-N9VlImpSsUjQvXoFjuDT0qFhrmogFHVnKGMJ1vvPR9qMtb4uTzakKD0-8VX56TFlLQNSvD0YLLQCnCpVuILOxbzrmrT6KRl0Z5oyTeHK64LEtBYZwIMUpyJecbHRGzTllEEIpFHcCNYf5VSbAnVizN56yCm5SQb0k8qgtLdzsDfGuwCT55-1jdb42aDcxg%3D%3D\" target=\"_blank\" rel=\"nofollow noopener\">Morning Star<\/a>,\u00a0<a title=\"\" href=\"http:\/\/globenewswire.com\/Tracker?data=_fp25Mz9QB0eyFAw9qIap8lNWoBYQYahmjYpMNjmgRFvwjD6Ty42QiqEhq0-oocF4EmW1l-XOPXtA5pAKWCqXcxQVDPmSERk9D2YEOqotc_iL0oeXwb_D1tj9E63NcuUZqfCAV_yt6nErvSSNRp_XW5Zq7lsocGCfhlI9TS07tuvayibMZpBnIqZgEKolS3EW1iNyGvKI3soFOUG14WvLNq8zYsuE33zYnqyIKhaBIgr_CJ7tuy0cFgzrKvOkKCfMm1_gDGgcmEF0Bseo4zv1fxAZ-4x2O_6chdSO02o85U%3D\" target=\"_blank\" rel=\"nofollow noopener\">EconoTimes<\/a>.<\/p>\n<p>AXIM<sup>\u00ae<\/sup> Biotech is a significant investment company for <a title=\"Medical Marijuana, Inc.\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=Vdkqi-qG9WTwFZLZUrp_79zbdv06xFbd32bEDFSHY5lxSFmQh-MxMDVACIZlZwkWF81izkFmvwo2sETgHdaC3RjnHOBopq_WFfbocHK6els=\" target=\"_blank\" rel=\"nofollow noopener\">Medical Marijuana, Inc.<\/a>, which holds 14,943,650 shares of common stock and 500,000 shares of preferred stock representing 45.5% equity interest in\u00a0the cutting-edge biotechnology innovator.<\/p>\n<p align=\"justify\"><strong><em>About Medical Marijuana Inc.<\/em><\/strong><\/p>\n<p align=\"justify\">The mission of Medical Marijuana, Inc. (OTC Pink:MJNA) is to be the premier cannabis and hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information on Medical Marijuana, Inc., please visit the company\u2019s website at: <a title=\"www.medicalmarijuanainc.com\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=a67Ir18PgKiaAQgIJsF-Ojs7jfdpDbS5ROYnT2N6OrJ_Teu9a7ODswPRJtU_F-43DmV0vT3PuhB-IZkK5aBLHNm5LJOvKvsk7iCOeO23gNba7-WXoTk8PmeQ1T_p7YSJ\" target=\"_blank\" rel=\"nofollow noopener\">www.medicalmarijuanainc.com<\/a><\/p>\n<p><strong>About AXIM Biotechnologies:<\/strong><\/p>\n<p>AXIM Biotechnologies (OTC:AXIM) is an innovative biotechnology company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products where we prioritize the well-being of our customers while embracing a solid fiscal strategy.\u00a0 For more information, visit the Company website at <a title=\"www.AXIMBiotech.com\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=u2sZKAucNgqhtLBrrItO04TE9e-IiNp_2eCLnj-O6Lkhqt03Tto7XPd2K_IbPXDlesjfImK1Wpow2jPJPl8efiqbkvnhv80_gFtGmHQoh2w=\" target=\"_blank\" rel=\"nofollow noopener\">www.AXIMBiotech.com<\/a>.<\/p>\n<p><em>FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE<\/em><\/p>\n<p><em>These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.<\/em><\/p>\n<p align=\"justify\"><em>FORWARD-LOOKING DISCLAIMER<\/em><\/p>\n<p align=\"justify\"><em>This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.<\/em><\/p>\n<p align=\"justify\"><em>LEGAL DISCLOSURE<\/em><\/p>\n<p align=\"justify\"><em>Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). Their companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AXIM\u00ae Biotech Discusses Patented Cannabinoid-Release Chewing Gum \u2013 MedChew RX\u2122; Future Patent-Pending Products Including: Oral Care, Skin Care, Suppository, and Ocular Treatments SAN DIEGO, Feb. 25, 2016 (GLOBE NEWSWIRE) \u2014 Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to the public and its shareholders that its portfolio investment, AXIM\u00ae Biotechnologies, Inc. (OTC:AXIM), participated in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2930,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[160,3,2],"tags":[183],"class_list":["post-3122","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-axim-biotechnologies","category-company-news","category-press-releases","tag-axim-biotechnologies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview - Medical Marijuana, Inc.<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview - Medical Marijuana, Inc.\" \/>\n<meta property=\"og:description\" content=\"AXIM\u00ae Biotech Discusses Patented Cannabinoid-Release Chewing Gum \u2013 MedChew RX\u2122; Future Patent-Pending Products Including: Oral Care, Skin Care, Suppository, and Ocular Treatments SAN DIEGO, Feb. 25, 2016 (GLOBE NEWSWIRE) \u2014 Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to the public and its shareholders that its portfolio investment, AXIM\u00ae Biotechnologies, Inc. (OTC:AXIM), participated in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/\" \/>\n<meta property=\"og:site_name\" content=\"Medical Marijuana, Inc.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MJNAInc\" \/>\n<meta property=\"article:published_time\" content=\"2016-02-26T06:42:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2016\/03\/AXIMip.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adminTorusBrand\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:site\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminTorusBrand\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/\"},\"author\":{\"name\":\"adminTorusBrand\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\"},\"headline\":\"AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview\",\"datePublished\":\"2016-02-26T06:42:36+00:00\",\"dateModified\":\"2016-02-26T06:42:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/\"},\"wordCount\":707,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"keywords\":[\"AXIM Biotechnologies\"],\"articleSection\":[\"Axim Biotechnologies\",\"Company News\",\"Press Releases\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/\",\"name\":\"AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview - Medical Marijuana, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\"},\"datePublished\":\"2016-02-26T06:42:36+00:00\",\"dateModified\":\"2016-02-26T06:42:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medicalmarijuanainc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"name\":\"Medical Marijuana, Inc.\",\"description\":\"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!\",\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\",\"name\":\"Medical Marijuana, Inc.\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"contentUrl\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"width\":512,\"height\":512,\"caption\":\"Medical Marijuana, Inc.\"},\"image\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MJNAInc\",\"https:\/\/twitter.com\/mjna_inc\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\",\"name\":\"adminTorusBrand\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"caption\":\"adminTorusBrand\"},\"sameAs\":[\"https:\/\/medicalmarijuanainc.com\"],\"url\":\"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview - Medical Marijuana, Inc.","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview - Medical Marijuana, Inc.","og_description":"AXIM\u00ae Biotech Discusses Patented Cannabinoid-Release Chewing Gum \u2013 MedChew RX\u2122; Future Patent-Pending Products Including: Oral Care, Skin Care, Suppository, and Ocular Treatments SAN DIEGO, Feb. 25, 2016 (GLOBE NEWSWIRE) \u2014 Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to the public and its shareholders that its portfolio investment, AXIM\u00ae Biotechnologies, Inc. (OTC:AXIM), participated in [&hellip;]","og_url":"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/","og_site_name":"Medical Marijuana, Inc.","article_publisher":"https:\/\/www.facebook.com\/MJNAInc","article_published_time":"2016-02-26T06:42:36+00:00","og_image":[{"width":1200,"height":500,"url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2016\/03\/AXIMip.jpg","type":"image\/jpeg"}],"author":"adminTorusBrand","twitter_card":"summary_large_image","twitter_creator":"@mjna_inc","twitter_site":"@mjna_inc","twitter_misc":{"Written by":"adminTorusBrand","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/#article","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/"},"author":{"name":"adminTorusBrand","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c"},"headline":"AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview","datePublished":"2016-02-26T06:42:36+00:00","dateModified":"2016-02-26T06:42:36+00:00","mainEntityOfPage":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/"},"wordCount":707,"commentCount":0,"publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"keywords":["AXIM Biotechnologies"],"articleSection":["Axim Biotechnologies","Company News","Press Releases"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/","url":"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/","name":"AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview - Medical Marijuana, Inc.","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/#website"},"datePublished":"2016-02-26T06:42:36+00:00","dateModified":"2016-02-26T06:42:36+00:00","breadcrumb":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicalmarijuanainc.com\/2016\/02\/26\/axim-biotechnologies-lays-out-powerhouse-ip-pipeline-cannabinoid-rd-in-interview\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medicalmarijuanainc.com\/"},{"@type":"ListItem","position":2,"name":"AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&amp;D in Interview"}]},{"@type":"WebSite","@id":"https:\/\/medicalmarijuanainc.com\/#website","url":"https:\/\/medicalmarijuanainc.com\/","name":"Medical Marijuana, Inc.","description":"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!","publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medicalmarijuanainc.com\/#organization","name":"Medical Marijuana, Inc.","url":"https:\/\/medicalmarijuanainc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/","url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","contentUrl":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","width":512,"height":512,"caption":"Medical Marijuana, Inc."},"image":{"@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MJNAInc","https:\/\/twitter.com\/mjna_inc"]},{"@type":"Person","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c","name":"adminTorusBrand","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","caption":"adminTorusBrand"},"sameAs":["https:\/\/medicalmarijuanainc.com"],"url":"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/"}]}},"_links":{"self":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/3122"}],"collection":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/comments?post=3122"}],"version-history":[{"count":0,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/3122\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media\/2930"}],"wp:attachment":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media?parent=3122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/categories?post=3122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/tags?post=3122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}